Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Payables (2016 - 2025)

Historic Payables for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $3.9 million.

  • Healthstream's Payables fell 1170.12% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1170.12%. This contributed to the annual value of $6.6 million for FY2024, which is 1121.23% down from last year.
  • As of Q3 2025, Healthstream's Payables stood at $3.9 million, which was down 1170.12% from $4.0 million recorded in Q2 2025.
  • Healthstream's 5-year Payables high stood at $22.2 million for Q3 2022, and its period low was $3.2 million during Q1 2025.
  • For the 5-year period, Healthstream's Payables averaged around $11.6 million, with its median value being $7.3 million (2022).
  • Its Payables has fluctuated over the past 5 years, first soared by 4215.76% in 2022, then tumbled by 8414.58% in 2023.
  • Over the past 5 years, Healthstream's Payables (Quarter) stood at $5.1 million in 2021, then surged by 42.16% to $7.3 million in 2022, then grew by 2.44% to $7.5 million in 2023, then fell by 11.21% to $6.6 million in 2024, then plummeted by 40.8% to $3.9 million in 2025.
  • Its Payables stands at $3.9 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.2 million for Q1 2025.